
Syntharmin 0.25mg Injection
Marketer
Iscon Life Sciences
Salt Composition
Methylergometrine (0.25mg)
Overview Syntharmin 0.25mg Injection
Uterine hemorrhage following childbirth or termination of pregnancy may be managed with Syntharmin 0.25mg Injection. This medication acts on uterine smooth muscle, enhancing contractility (tone, frequency, and strength of contractions) to minimize blood loss. Administration is strictly by a physician in a hospital setting via intravenous or intramuscular injection; self-administration is prohibited. Dosage and frequency are tailored to individual needs and determined by your physician based on your specific condition and response. Common adverse effects include headache, elevated blood pressure, and convulsions. Report any concerning or worsening symptoms to your doctor; management strategies may be available. Alcohol consumption should be avoided during treatment. Prior to commencing therapy, inform your physician of any pre-existing heart conditions or hypertension, as well as all other medications you are currently using, as interactions may affect Syntharmin's efficacy or mechanism.
Primary Ingredients of Syntharmin 0.25mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Syntharmin 0.25mg Injection
Hemorrhage postpartum
Major Benefits of Syntharmin 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Syntharmin 0.25mg Injection:
- High blood pressure
- Headache
- Seizure
How to use Syntharmin 0.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Syntharmin 0.25mg Injection works:
Ergonovine 0.25mg injection, a derivative of ergot, induces prolonged uterine smooth muscle contractions. This vascular constriction effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Syntharmin 0.25mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Syntharmin 0.25mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician; research in both animal and human studies has revealed considerable adverse effects on fetal development.
Breast feedingCAUTION
Administering Syntharmin 0.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingCONSULT YOUR DOCTOR
The effect of Syntharmin 0.25mg Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Syntharmin 0.25mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding Syntharmin 0.25mg Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Syntharmin 0.25mg Injection :
NA
Facts to Know About Syntharmin 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Category | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Action Class | Drugs that stimulate uterine contractions and induce abortion |
